These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6531025)

  • 1. Improvement of the efficacy and safety of oral methoxsalen photochemotherapy.
    Momtaz-T K; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():175-8. PubMed ID: 6531025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications of PUVA.
    Momtaz-T K; Fitzpatrick TB
    Dermatol Clin; 1995 Oct; 13(4):867-73. PubMed ID: 8785890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).
    Bond CA; Grant K; Boh L
    Am J Hosp Pharm; 1981 Jul; 38(7):990-5. PubMed ID: 7020414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PUVA combination therapy.
    Morison WL
    Photodermatol; 1985 Aug; 2(4):229-36. PubMed ID: 3903677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
    Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
    J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemotherapy in psoriasis and other skin diseases.
    Adrian RM
    Am Fam Physician; 1981 May; 23(5):95-100. PubMed ID: 7234635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
    Roelandts R
    Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis.
    Boer J; Hermans J; Schothorst AA; Suurmond D
    Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ambulatory treatment of psoriasis].
    Tapernoux B
    Ther Umsch; 1989 Feb; 46(2):123-7. PubMed ID: 2928980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    Wolff K; Hönigsmann H
    Natl Cancer Inst Monogr; 1984 Dec; 66():159-64. PubMed ID: 6531023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term risks of psoralen and UV-A therapy for psoriasis.
    Farber EM; Abel EA; Cox AJ
    Arch Dermatol; 1983 May; 119(5):426-31. PubMed ID: 6342539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).
    Pariser DM; Wyles RJ
    J Am Acad Dermatol; 1980 Sep; 3(3):248-50. PubMed ID: 7451691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis therapy: a current perspective.
    Lowe NJ
    West J Med; 1983 Aug; 139(2):184-9. PubMed ID: 6195826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
    Stern RS; Momtaz K
    Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema resulting from suberythemogenic doses of ultraviolet radiation and methotrexate.
    LeVine MJ
    Arch Dermatol; 1981 Oct; 117(10):656-8. PubMed ID: 7283458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.